Cargando…
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
Epstein-Barr virus (EBV) is the causal agent in the etiology of Burkitt's lymphoma and nasopharyngeal carcinoma and is also associated with multiple human malignancies, including Hodgkin's and non-Hodgkin's lymphoma, and posttransplantation lymphoproliferative disease, as well as spor...
Autores principales: | Ghosh, Sajal K., Perrine, Susan P., Faller, Douglas V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303631/ https://www.ncbi.nlm.nih.gov/pubmed/22500168 http://dx.doi.org/10.1155/2012/509296 |
Ejemplares similares
-
The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018) -
Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019) -
Novel Therapeutics for Epstein–Barr Virus
por: Andrei, Graciela, et al.
Publicado: (2019) -
The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015) -
Vaccination against the Epstein–Barr virus
por: Rühl, Julia, et al.
Publicado: (2020)